Evidence brief · printable

Opioid Use Disorder evidence brief

One page, every section sourced. Print it or bring it on your phone.

Print or save as PDF Fits on one A4 or Letter page.

Opioid Use Disorder: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/opioid-use-disorder.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Ketorolac 2 trials
  • Paracetamol 1000 Mg Oral Tablet 2 trials
  • ANS-6637 1 trial
  • Autonomic neural blockade 1 trial
  • Buprenorphine/naloxone 1 trial
  • CAM2038 1 trial

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Education, coaching and self-management 72 trials · 38 completed · 19 with results
  • Behavioural treatment for alcohol, smoking and drug use 29 trials · 18 completed · 10 with results
  • Care coordination, navigation and outreach 27 trials · 16 completed · 9 with results
  • Cognitive behavioural and related therapies 20 trials · 12 completed · 5 with results
  • Psychotherapy, counselling and peer support 35 trials · 14 completed · 3 with results
  • Mindfulness, meditation and relaxation 19 trials · 9 completed · 2 with results

Natural products (RepurpOS Moderate tier)

Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.

  • Passionflower

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • Ketamine for Opioid Use Disorder NCT06943859
  • MethaLoad Dose-Finding Study NCT06877858
  • Semaglutide for Helping Opioid Recovery NCT06639464
  • Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and… NCT06768814
  • PRoducing Outcome Measures for OTP Quality Improvement NCT07214389
  • Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment NCT07024498

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Among 27 trials of care delivery and health services found, none measured pain 47 trials of other approaches did
  • Among 8 trials of exercise and physical activity found, none measured pain 47 trials of other approaches did
  • Among 27 trials of care delivery and health services found, none measured cognition 18 trials of other approaches did
  • Mind-body and psychological approaches: quality of life 5 trials, no results posted yet
  • Rehabilitation and therapy services: pain 4 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (456 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.